Is inhibition of mast cell mediator release relevant to the clinical activity of anti-allergic drugs?
- 1 June 1986
- journal article
- Published by Springer Nature in Inflammation Research
- Vol. 18 (3-4) , 288-293
- https://doi.org/10.1007/bf01964986
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Disodium cromoglycate inhibits activation of human inflammatory cells in vitroJournal of Allergy and Clinical Immunology, 1987
- Passive Anaphylaxis in Human Lung Fragments as a Model for Testing Anti-Allergic Drugs: Its Variability and ConstraintsInternational Archives of Allergy and Immunology, 1983
- Neutrophil chemotactic factor of anaphylaxisJournal of Allergy and Clinical Immunology, 1982
- Inhibitory Effect of KWD 2131, Terbutaline, and DSCG on the Immediate and Late Allergen-Induced BronchoconstrictionAllergy, 1981
- ROLE OF BRONCHIAL IRRITANT RECEPTORS IN ASTHMAThe Lancet, 1981
- Blood histamine levels after exercise testingClinical and Experimental Allergy, 1979
- Studies on the Mechanism of Tachyphylaxis to Disodium CromoglycateInternational Archives of Allergy and Immunology, 1977
- RECENT DEVELOPMENTS CONCERNING THE MAST CELL AND THE MODE OF ACTION OF DISODIUM CROMOGLYCATEAllergy, 1975
- Immediate and late bronchial obstructive reactions to inhalation of house dust and protective effects of disodium cromoglycate and prednisoloneJournal of Allergy and Clinical Immunology, 1971
- Effect of Disodium Cromoglycate on Exercise-induced AsthmaBMJ, 1968